Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company TheraVida Inc.
DescriptionOral formulation of oxybutynin, a competitive antagonist of M1, M2 and M3 subtypes of the muscarinic acetylcholine receptor, and pilocarpine, a non-selective muscarinic receptor agonist
Molecular Target Muscarinic acetylcholine receptor M1 (CHRM1) (HM1) ; Muscarinic receptor
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationExcessive sweating
Indication DetailsTreat primary focal hyperhidrosis
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today